INTRODUCTION
Purkinje cell protein-2 (Pcp2; also known as L7) is an abundant Purkinje cell protein whose function remains unknown. Pcp2 was first identified as a gene candidate [1] to account for the ataxia and spontaneous pcd (Purkinje cell degeneration) in autosomal recessive pcd mice [2] . However, subsequent studies demonstrated that Pcp2 was not the gene responsible for pcd in these animals. The expression pattern of Pcp2 is limited to specific neurons (cerebellar Purkinje cells and retinal bipolar neurons [1, 3, 4] ) and coincides with the maturation of Purkinje cells and formation of synaptic connections. Message levels in the mouse increase from postnatal day 2 to 15 and remain relatively constant thereafter [3, 5, 6] . Although these findings initially suggested a role for Pcp2 in Purkinje cell development, knockout mice for Pcp2 have been characterized by two groups and there were no significant anatomic, behavioural or motor deficits identified [7, 8] . In 1999, we identified an interaction of Pcp2 and the Gα o/i family of heterotrimeric G-proteins [9] . We recently confirmed this interaction in vivo by co-immunoprecipitation from mouse cerebellum and eyes, and co-localized Pcp2 with Gα o in the distal processes of cerebellar Purkinje cells including axonal endings and dendritic spines [10] . A second splice form of Pcp2 was recently identified in rodents and humans and both isoforms are differentially expressed in developing dendrites during peak synaptogenesis [11] .
Pcp2 is a G-protein regulator, one of a family of proteins containing a Goloco or GPR (G-protein regulatory) motif. This family is named for the G i/o interacting protein Loco, the Drosophila RGS 12 (regulator of G-protein signalling 12) homologue [12] and members of this family interact with Gα o /Gα i subunits to inhibit GDP release [13] [14] [15] [16] [17] . The functions of GPR family members are not well established and the lack of suitable cultured Purkinje cell lines has contributed to the difficulties in defining Pcp2 function(s). To begin addressing the function of Pcp2 in neurons, we developed a cell culture model of inducible expression of Pcp2 in PC12 cells (rat pheochromocytoma cells). The signalling networks for differentiation of PC12 cells are highly developed and ideally suited for testing the hypothesis that Pcp2 modulates neuronal differentiation [18] . Furthermore, PC12 cells do not express endogenous Pcp2, thereby permitting establishment of a model system to study the effect of Pcp2 on neuronal properties. We found that Pcp2 stimulates differentiation in PC12 cells by increasing the fraction of cells with neurites and stimulating NGF (nerve growth factor)-induced neurite outgrowth. Pcp2 stimulated basal Ras and p38 MAPK (mitogen-activated protein kinase) activities and further enhanced NGF-stimulated signalling through this pathway. The effects of Pcp2 were blocked by treatment with pertussis toxin, inhibiting p38 MAPK, or by interference with signalling through Gβγ subunits. These studies provide evidence for Pcp2 regulation of neuronal differentiation in PC12 cells and implicate an important role for Gβγ .
EXPERIMENTAL

Tet-off Pcp2-PC12 cell lines and anti-Pcp2 antibody
GST-Pcp2 fusion protein was purified using standard techniques as described previously [9] . The full-length fusion protein was used to create a rabbit polyclonal antibody ( 
Cell lysates and Western blot
Cell lysates were prepared in TB (tissue buffer; 20 mM Tris, pH 7.5, 5 mm EDTA, 2 mM EGTA, 30 mM NaF, 40 mM β-glycerophosphate, 10 mM sodium pyrophosphate, 2 mM sodium orthovanadate and 1 % Triton X-100 with protease inhibitor cocktail; Roche) and membrane preparation and Western blots were performed as described previously [19] .
Immunohistochemistry and microscopy
Frozen sections of mouse cerebellum were fixed in 4 % (w/v) paraformaldehyde, blocked with 5 % (v/v) goat serum, 5 % horse serum and 0.2 % Triton X-100 for 30 min followed by incubation with Pcp2 antibody or preimmune serum at 1:1000 dilution followed by biotinylated anti-rabbit serum and 0.2 % streptavidin-CY3 (Zymed Laboratories, San Francisco, CA, U.S.A.). For Pcp2 staining of PC12 cells, cells were grown on poly-L-lysine coated glass coverslips. For phase contrast, cells were fixed with cacodylate buffer (2 % paraformaldehyde, 2.5 %, w/v, glutaraldehyde and 50 mM sodium cacodylate, pH 7.2-7.4). For immunofluorescence, cells were fixed in 4 % paraformaldehyde, blocked in 5 % goat serum, 5 % horse serum, 1 % BSA and 0.5 % Triton X-100 in PBS and incubated with Pcp2 antibody at 1:500 followed by incubation with FITClabelled goat anti-rabbit secondary antibodies (Molecular Probes, Eugene, OR, U.S.A.) at 1:200 dilution. Long-term NGF (100 ng/ ml; Sigma) stimulation (0-72 h) was done in standard media with 1 % fetal bovine serum. Images were obtained using a Nikon Labophot-2 microscope and Spot Digital camera and software (Diagnostic Instruments, Sterling Heights, MI, U.S.A.; version 3.5.7) and Figures assembled using Adobe Photoshop and Illustrator (San Jose, CA, U.S.A.). Neurites were defined as processes longer than the width of the cell body. For each experiment, cells were imaged and neurite length determined with SpotSoftware. Total numbers of neurites, individual lengths, and cells were counted, and tabulated using GraphPad Prism (GraphPAD Software for Science, San Diego, CA, U.S.A.). Total neurite length was divided by the total number of cells counted to yield neurite length/cell. Independent experiments and analysis were performed at least twice for each condition with number of cells ranging from 30 to 100.
Ras activation
Ras activity was determined by precipitating Raf-1 RBD (Ras binding domain)-GST (glutathione S-transferase) from PC12 cell lysates according to the manufacturer's instructions (Upstate Biotechnology, Waltham, MA, U.S.A.). NGF was added (100 ng/ ml) to media for short-term stimulation after overnight serum starvation. Cells were washed with PBS and lysates were harvested in MLB buffer (25 mM Hepes, pH 7.5, 150 mM NaCl, 1 % Triton X-100, 10 mM MgCl 2 , 1 mM EDTA and 2%, v/v, glycerol). For controls, lysates (500 µg) from + Dox cells were incubated with 10 µl of 0.5 M EDTA and GTP[S] (100 µM) (positive) or 2 mM GDP (negative control) at 30
• C for 30 min. For each condition, cell lysates (500 µg) were incubated with 20 µg of Raf-1 RBD-GST agarose at 4
• C for 45 min. Reactions were terminated by adding 32 µl of 1 M MgCl 2 on ice followed by centrifugation of the beads and three washes in MLB buffer. Beads were resuspended in SDS/PAGE sample buffer, boiled and analysed by Western blot with mouse monoclonal anti-Ras antibody.
ERK1/2 (extracellular-signal-regulated kinase 1/2) and p38 MAPK activation
Basal-and NGF-stimulated activities were determined on identical amounts of PC12 cell lysates obtained from PC12 cells +/− Dox and +/− NGF as described above. Cells were washed with PBS, scraped and lysates prepared in TB as described above. Protein concentration was determined and identical amounts of total proteins were loaded on SDS/PAGE gels followed by Western-blot analysis with antibodies to total ERK1/2, phospho-ERK1/2, total p38 MAPK and phospho-p38 MAPK (all from Cell Signaling, Beverly, MA, U.S.A.).
Transient Pcp2 and β-ARK (β-adrenergic receptor kinase) expression in PC12 cells
PC12 cells (obtained from R. Diaz, Children's Hospital, Boston, MA, U.S.A.) were transiently transfected on poly-L-lysine glass coverslips in 12 mm culture plates with Pcp2 and enhanced GFP (ClonTech Laboratories; 1 µg each) using Lipofectamine TM 2000 (Gibco BRL/Life Technology) according to the manufacturer's instructions. NGF (100 ng/ml) was added 48 h after transfection in 1 % serum and cultured for an additional 72 h. For β-ARK C-terminus (provided by Dr R. Lefkowitz, Duke University Medical Center, Durham, NC, U.S.A.) transfection, Pcp2-PC12 cells in + Dox were transfected with GFP and pRK5 (1 µg each) or GFP and pcDNA3 and changed to − Dox medium at 24 h. NGF was then added for an additional 72 h and coverslips fixed and imaged as described above.
Pertussis toxin treatment
PC12 cells growing on coverslips in + Dox media were incubated with pertussis toxin (List Biologicals Laboratories, Campbell, CA, U.S.A.) at 150 nM (a concentration previously shown to inhibit Gα o/i in PC cells [20] ). At the time pertussis toxin was added, the cells were switched into − Dox medium and treated with NGF (100 ng/ml) for 72 h. Coverslips were then fixed, imaged and neurite length determined as described above. ) and these cells were replated in p60 culture dishes in low serum − Dox medium overnight. Cells were serum-starved overnight and stimulated the next day with NGF followed by measurement of Ras activity as described above.
Statistics and quantification
Western blots with exposures in the linear range were scanned using a desktop scanner and the images were analysed in NIH Image 1.63 (Wayne Rasband). Relative intensities of Ras, phospho-ERK1/2 and phospho p38 were normalized to the total amount of each protein in each experiment and results in arbitrary units were plotted using GraphPad Prism. All results are expressed as the means + − S.D. or the range. Statistical significance was determined using two-tailed t test.
RESULTS
Establishment of Pcp2 inducible PC12 cell lines
To facilitate studies of Pcp2, a rabbit polyclonal antibody to GST-Pcp2 fusion protein was generated. Figure 1 (A) shows that this antibody (1:5000 dilution) detects GST-Pcp2 at approx. 40 kDa, thrombin-cleaved Pcp2 (from GST-Pcp2) at approx. 16 kDa and a similar sized protein migrating as a doublet in mouse cerebellum. Cleaved Pcp2 from GST contains five additional amino acids and migrates slightly slower than Pcp2 in cerebellum. Pcp2 is often seen as a doublet possibly reflecting detection of the two known isoforms [11] . Preincubation of the antibody with GST-Pcp2 fusion protein nearly completely inhibited the ability of the antibody to detect Pcp2 protein on Western blots ( Figure 1A ). Hygromycin-resistant PC12 cells were screened for Pcp2 expression by Western-blot analysis in − Dox. As shown in Figure 1 (B), PC12 cells (Tet-off parental clone) did not express Pcp2. Of the eight positive clones, two were chosen for additional analysis. The time course of Pcp2 protein expression for one clone is shown in Figure 1(B) . Removal of Dox induced Pcp2 protein expression within 24 h with levels that peaked and Pcp2 is localized in cerebellar Purkinje cells throughout the cell body, axon and dendrites [4, 10] . The utility of the Pcp2 antibody for immunolocalization was confirmed by detecting a similar staining pattern in mouse cerebellum ( Figure 1C ) and there was no detectable staining with preimmune serum ( Figure 1C) . In non-differentiated PC12 cells, short processes were visible and Pcp2 was localized in the cell body and the processes (Figure 1D, panel B) . In differentiated PC12 cells expressing Pcp2, the protein distribution was similar to Purkinje cells with expression in neurites and in the cell body ( Figure 1D , panel C). Pcp2 was excluded from the nucleus (confirmed by co-staining with 4,6-diamidino-2-phenylindole; results not shown) and short-term stimulation with NGF did not result in transient accumulation in the nucleus (results not shown). As expected from previous studies [4] , there was co-localization of endogenous Gα o with expressed Pcp2 in neurites and cell body of Pcp2-PC12 cells (results not shown).
Pcp2 stimulates differentiation in PC12 cells
The effects of Pcp2 on differentiation in PC12 cells were determined by analysing the fraction of cells with neurites and by measuring total neurite length/cell in Pcp2-PC12 cells. In the absence of NGF, inducing Pcp2 expression led to a significant increase in the fraction of cells with neurites ( Figure 2A) . After switching to − Dox medium, there was an increase in the fraction of cells bearing neurites from approx. 2-3 % up to 15 %, whereas those cells maintained in + Dox medium (no Pcp2 expression) remained unchanged (Figure 2A 
Pcp2 expression stimulates Ras
There are two main receptor-mediated pathways for differentiation in PC12 cells. One pathway utilizes a GPCR (G-proteincoupled receptor) and its ligand PACAP (pituitary adenylate cyclase-activating peptide) that stimulates adenylate cyclase and PKA (protein kinase A) through Gαs and Gαq. The other pathway is through TrkA which activates several proteins including Shc, Src and PI3K (phosphoinositide 3-kinase) (see [18] ). We measured cAMP levels in PC12 cells +/− Pcp2 expression and failed to detect any difference (by ELISA; results not shown). We next measured basal Ras activity in PC12 cells +/− Pcp2 expression. Figure 3(A) shows total Ras in cellular lysates and activated Ras precipitated with the Raf-1 RBD-GST fusion protein under basal conditions. PC12 cell lysates from + Dox cells were used for controls; lysates were incubated with GDP (negative control) and GTP[S] (positive control) before pull down with Raf-1 RBD-GST fusion protein. In PC12 cells with Pcp2 expression (− Dox) there was a 5-fold increase in basal Ras activation relative to the + Dox control ( Figure 3B ). Based upon these findings and the fact that Pcp2 does not interact with the G-proteins in PACAP signalling system, we examined the effects of NGF on Ras activation in Pcp2 expressing PC12 cells. The addition of NGF led to a significant increase in Ras activation (2-fold) at 5 min in Pcp2-PC12 cells relative to the controls ( Figures 3C and 3D ) and this difference persisted through 30 min of NGF stimulation. Since Ras is a critical intermediate in the differentiation pathway of PC12 cells [18] and stimulates activation of downstream MAPKs, ERK1/2 activation was next examined. Somewhat surprisingly, there were no differences in basal or NGF-stimulated ERK1/2 activity in Pcp2-PC12 cells when compared with the control (Figures 3E and 3F ).
Pcp2 expression stimulates p38 MAPK
In PC12 cells, Ras activates ERK1/2 through Raf, but can also directly activate p38 MAPK. To determine if p38 MAPK was activated downstream of Ras in Pcp2 expressing cells, total and phospho-p38 levels were determined by Western-blot analysis in non-stimulated cells. Figures 4(A) and 4(B) show that under basal conditions, there was a 3-4-fold increase in phospho-p38 indicating activation in Pcp2-PC12 cells in comparison with controls (+ Dox). NGF stimulation resulted in rapid increases in phospho-p38 ( Figures 4C and 4D ) that were significantly greater (3-4-fold) in Pcp2 expressing cells. The importance of p38 activation in stimulating differentiation with Pcp2 expression was confirmed by pretreating the cells with the p38-specific inhibitor SB203580. This inhibitor specifically blocks p38 activity [21] and is effective and specific in PC12 cells [22] . Inhibition of p38 MAPK in Pcp2-PC12 cells resulted in a similar fraction of cells with neurites, when compared with control cells ( Figure 4E ). Furthermore, inhibition of p38 MAPK in NGF-stimulated PC12 cells led to neurite lengths that were equivalent in PC12 cells +/− Pcp2 expression ( Figure 4E ). Taken together, these results reveal that Pcp2 activates Ras-p38 MAPK pathway and synergizes the effects of NGF stimulation.
Pertussis toxin and co-expression of β-ARK inhibits Pcp2-induced phenotype and Ras activation
GPR proteins such as Pcp2 stabilize Gα o/i subunits in the GDPliganded conformation and this may activate signalling pathways mediated by Gβγ [16] . To determine if inhibition of Gα o/i by pertussis toxin inhibited the Pcp2 stimulated effects on neurite growth, PC12 cells were treated with 150 nM pertussis toxin before induction of Pcp2 protein expression. Figure 5(A) shows that pertussis toxin treatment of PC12 cells without Pcp2 expression (+ Dox) has no effect on neurite growth. With Pcp2 expression, neurite growth is stimulated (as shown in prior Figures ), but pretreatment with pertussis toxin completely inhibited this effect. NGF-stimulated neurite growth was inhibited by pertussis toxin to lengths less than those seen in controls. These findings indicate that Pcp2 requires Gα and/or Gβγ to stimulate neurite growth. The effects of pertussis toxin on neurite growth were independent of any changes in cell viability. Trypan Blue staining and counting of detached cells at specific times +/− pertussis toxin showed no significant differences (results not shown).
Gβγ released via activation of Gα i -coupled receptors can directly activate Ras [23] . To test whether Gβγ released from Gα o/i after complexing with Pcp2 could account for Ras stimulation in PC12 cells with Pcp2 expression, Gβγ signalling was blocked by transient transfection with the β-ARK C-terminus that has previously been shown to inhibit Gβγ -mediated signalling [24] . PC12 cells (+ Dox) were transiently transfected with β-ARK C-terminus or pcDNA3 (vector) plus GFP. One day after transfection, the cultures were switched to − Dox medium or parallel cultures kept in + Dox medium and stimulated with NGF for 72 h. Figure 5B ). β-ARK transfection into PC12 cells expressing Pcp2 results in a significant reduction in total neurite length, when compared with controls (black bars; Figure 5B ). The length of 
DISCUSSION
The function of Pcp2 has remained elusive since its discovery as an abundant Purkinje cell protein in 1988. Previous studies have hinted at a role for Pcp2 in Purkinje cell differentiation but direct evidence has been lacking [1, 10, 11] . Direct study of Pcp2 in Purkinje cells is difficult due to the lack of suitable cell culture models. The PC12 model neuron recapitulates many fundamental processes important for neuronal differentiation, and permits the effects of Pcp2 expression on neuronal differentiation to begin to be addressed. Now it is shown that Pcp2 stimulates neurite formation and NGF-stimulated neurite growth through activation of Ras and p38 MAPK pathways (without ERK1/2 activation). Inhibition of Gα o/i with pertussis toxin, inhibition of p38 MAPK activity or sequestering of Gβγ with β-ARK C-terminus blocks Pcp2-stimulated differentiation. These results provide the first direct evidence that Pcp2 modulates neuronal differentiation. However, the results obtained in this study using the PC12 cell model neuron limit firm conclusions about the relevance of these findings for cerebellar Purkinje cells. The cellular environment of the Purkinje is likely to differ significantly from the PC12 cell. Nevertheless, many fundamental neuronal processes have been identified using the PC12 cell model and the insights from this study will permit future studies in Purkinje cells to validate the hypotheses generated in this model system. The function of Pcp2 has been difficult to elucidate due, in part, to the normal phenotype observed in knockout mice and the lack of suitable models for the present study. There are several lines of evidence indicating that Pcp2 has important functions in Purkinje cells and retinal bipolar neurons. It is an abundant protein in Purkinje cells with message levels similar to those of actin and tubulin [5] . The protein is widely distributed throughout the cell body, in the nucleus and cytosol including axonal and dendritic compartments ( [4] and seen in Figure 1 ). In addition, there are at least two highly conserved isoforms in mammals, and the proteins are developmentally regulated during times of peak synaptogenesis [1, 11] . Finally, Pcp2 is a GPR family member, and it directly interacts and co-localizes with Gα o in cerebellar Purkinje cells [10] . Based upon these observations and the absence of related proteins other than GPR family members, it is likely that the lack of a phenotype in the knockout mice results from developmental compensation from another GPR protein. This raises the possibility that in addition to other cellular functions, GPR family members may regulate differentiation in a variety of specialized cells.
GPR proteins share conserved GPR or Goloco domains that are conserved 19 amino acid motifs. GPR proteins contain one or more of these domains and share the basic properties of binding to the Gα o /Gα i family of heterotrimeric G-proteins and inhibiting GDP release from Gα [12] . Pcp2 contains one or two GPR domains depending upon the isoform [11] and other GPR family members contain up to four GPR domains. Other members of the GPR family include AGS3 (activator of G-protein signalling 3), LGN (Leu-Gly-Asn), Rap1Gap, RGS 12,14 [12, 25] and the recently described AGS4 [26] . AGS3 and LGN contain four GPR domains and both proteins are widely expressed in the central nervous system [27] .
LGN is ubiquitously expressed in numerous tissues, whereas AGS3 is primarily enriched in the brain. Within the central nervous system, both proteins are found in all major regions including the cerebellum. Developmental analysis revealed that both proteins are expressed in the cerebellum at postnatal day 1 and levels of LGN remain constant up to day 22, while AGS3 levels are significantly reduced at day 22 [27] . Thus either AGS3 or LGN could potentially compensate in the Pcp2 null mice. Several investigators have implicated possible functions for AGS3 and LGN in the process of cytokinesis. The Drosophila homologue of AGS3, PINS (partner of inscuteable) associates with Gα i , is asymmetrically localized during mitosis, and mediates correct spindle formation in dividing cells [28, 29] .
LGN is redirected to the cortex of dividing cells in a Gα-dependent manner and interfering with LGN function disrupts cellcycle progression [30] . LGN (but not AGS3) was found in the nucleus of dividing cells, including PC12 cells, and moves to the midbody, where it associates with F-actin [27] . In Caenorhabditis elegans, two GPR proteins interact with LIN-5, are co-localized to the mitotic spindle and activate G-protein signalling to affect spindle force [31, 32] . Both LGN and AGS3 contain loose nuclear localization signals, but only LGN was found in the nucleus of PC12 cells [27] . Pcp2 does not contain a clear nuclear localization signal, and in PC12 cells fails to localize within the nucleus.
The results of the present study reveal that Pcp2 stimulates differentiation in PC12 cells and synergistically increases neurite growth with NGF stimulation. Although there are important differences between Pcp2 expressed in PC12 cells and in cerebellar Purkinje cells, these findings are the first demonstration that Pcp2 can stimulate neuronal differentiation. Pcp2 expression leads to robust Ras activation under basal conditions and preferentially activates p38 MAPK but not ERK1/2. This selective MAPK activation could occur, if the Pcp2-Ras complex was restricted to specific cellular domains without access to ERK1/2. Activation of p38 MAPK is sufficient for stimulating differentiation in PC12 cells [22] and inhibiting p38 MAPK with SB203580 indicates that p38 is critical for Pcp2-stimulated differentiation. Pertussis toxin does not significantly affect the differentiation pathway in PC12 cells [18] and this is confirmed in the present study ( Figure 5A) . A potential role for pertussis toxin G-proteins in NGF-stimulated differentiation, however, is suggested by the finding that pertussis toxin blocked NGF-stimulated ERK1/2 activation [33] and pertussis toxin-sensitive G-proteins were shown to regulate NGF-induced phosphorylation of tuberin, an important regulator of NGF-stimulated neuronal surivival in PC12 cells [34] . Furthermore, NGF treatment increases pertussis toxin G-protein levels [35] . Pretreatment of Pcp2 expressing PC12 cells with pertussis toxin suppressed NGF-stimulated neurite growth to below control levels ( Figure 5A ). Ribosylation of endogenous Gα o/i is likely to prevent interaction with Pcp2 suggesting that the inhibited neurite outgrowth may result from signalling via unbound or free Pcp2. Taken together, these observations suggest that pertussis toxin-sensitive G-proteins may have important roles in regulating neuronal differentiation in specific cell types, and raises the possibility that Pcp2 can signal independently of Gα o/i .
The binding of Pcp2 to Gα o/i could release Gβγ leading to Ras activation. The observation that Pcp2 expressing PC12 cells fail to show enhanced differentiation, when Gβγ signalling is blocked with β-ARK expression is consistent with this mechanism. The partially inhibited Ras activation in Pcp2-PC12 cells expressing β-ARK supports Gβγ -mediated Ras activation in this model. However, this does not exclude other potential mechanisms and direct evidence for a signalling role of Gα o/i -Pcp2 remains to be found. The inhibition of neurite length by pertussis toxin to levels below the controls could be consistent with an additive signal from Gα o/i -Pcp2. A recent study of the effects of Pcp2 (L7) on P-type calcium channels in oocytes found that Pcp2 inhibited the channel [36] . There was no effect without receptor activation indicating that dissociation of Gα o/i βγ is necessary; a finding consistent with our results. However, there was complex regulation seen when either Gβγ or Gα i/o was overexpressed. Additional mechanisms are possible in the Pcp2-PC12 cell model system. For example, p38 MAPK can be activated by upstream adenylate cyclase-PKA stimulation, but this would not account for the enhanced Ras activity observed with Pcp2 expression. In addition, the effects of Gβγ on adenylate cyclase depend upon the isoform, and the absence of any significant difference in cAMP levels with Pcp2 expression suggests that Gβγ released via this mechanism is not affecting the net balance of adenylate cyclase activity. Finally, we have not excluded the possibility that Pcp2 alone or in complex with a Gα subunit contributes to Ras activation through other mechanisms.
The results of the present study provide the first evidence for a role of Pcp2 in regulating neuronal differentiation and reveal new insights into the signalling mechanisms. However, the findings in the present study using PC12 cells need to be corroborated in a Purkinje cell system. Although a highly abundant protein in cerebellar Purkinje cells, the function(s) of Pcp2 have been difficult to elucidate. These findings indicate that Pcp2 stimulates differentiation in the PC12 model neuron through Gβγ , Ras and p38 activation. This will permit future studies addressing these mechanisms directly in Purkinje cells and is likely to provide additional insights into novel functions for GPR family members.
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